Date: Friday, February 28, 2014
Time: 12:00 PM - 1:00 PM
Building: 1430 Tulane Avenue (Medicine) in Room 4700
Location: downtown campus
Other Information: Pharmacology Conference Room
The overall goal of my laboratory is to better understand the regulation of vascular function and structure in diabetes in order to prevent, delay or reverse diabetes-associated complications including stroke and cognitive impairment. In collaboration with Dr. Susan Fagan, we have made the interesting observation that there is significant cerebral neovascularization in type 2 diabetic rats and when ischemia/reperfusion injury occurs, diabetic animals develop bleeding into the brain, a dreaded complication of stroke. Our efforts are focused on how diabetes alters the expression and function of key mediators that are critical for vascular integrity and function. These studies are important to identify potential mechanisms contributing to cognitive decline in diabetes as well as identifying how an ischemic injury superimposed on this existing pathology affect functional outcomes and recovery following stroke. In addition, based on the clinical evidence which suggests that acute hyperglycemic patients suffer the worst outcomes of stroke, in collaboration with Dr. Askiel Bruno from Department of Neurology, we are investigating the mechanisms that mediate greater vascular and neuronal injury in hyperglycemic stroke.
For more information on Dr. Ergul, click here.
Sponsored by: Pharmacology Department
Admission: Admission is charged
Attendance: See description
Open to: Alumni, Faculty, Graduate students, Undergraduates, Visitors
For more information contact Sewann Strong via email to firstname.lastname@example.org or by phone at 504-988-5444
Calendar of Events, Tulane University 504-865-5000 email@example.com